| Title | Journal of Labelled Compounds and Radiopharmaceuticals |
| Abbreviation | J. Label. Compd. Radiopharm. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Analytical Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Biochemistry (Q4); Drug Discovery (Q4); Organic Chemistry (Q4); Spectroscopy (Q4) |
| h-index | 56 |
| Overall Rank/Ranking | 17722 |
| SCImago Journal Rank (SJR) | 0.271 |
| Impact Score | 0.96 |
| Publisher | John Wiley and Sons Ltd |
| Country | United Kingdom |
| ISSN | 03624803, 10991344 |
| Best Quartile | Q3 |
| Coverage History | 1976-2024 |
The Official Journal of the International Isotope Society
The Journal of Labelled Compounds and Radiopharmaceuticals publishes original scientific manuscripts dealing with all aspects of research in labelled compound preparation and application. This includes areas such as analytical control, self radiolysis, quality control handling, storage, and tracer methods used in chemical, biochemical, biological, pharmacological, medical, genetic, agricultural and geochemical research. All radionuclides and enriched stable nuclides are included.
Journal of Labelled Compounds and Radiopharmaceuticals is a journal covering the technologies/fields/categories related to Analytical Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Biochemistry (Q4); Drug Discovery (Q4); Organic Chemistry (Q4); Spectroscopy (Q4). It is published by John Wiley and Sons Ltd. The overall rank of Journal of Labelled Compounds and Radiopharmaceuticals is 17722. According to SCImago Journal Rank (SJR), this journal is ranked 0.271. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 56. The best quartile for this journal is Q3.
The ISSN of Journal of Labelled Compounds and Radiopharmaceuticals journal is 03624803, 10991344. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Journal of Labelled Compounds and Radiopharmaceuticals is cited by a total of 143 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Journal of Labelled Compounds and Radiopharmaceuticals is 0.96, which is computed in 2025 as per its definition. Journal of Labelled Compounds and Radiopharmaceuticals IF is increased by a factor of 0.1 and approximate percentage change is 11.63% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Journal of Labelled Compounds and Radiopharmaceuticals is 0.96. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.96 |
| 2023 | 0.86 |
| 2022 | 1.66 |
| 2021 | 1.72 |
| 2020 | 1.66 |
| 2019 | 1.52 |
| 2018 | 1.15 |
| 2017 | 1.27 |
| 2016 | 1.75 |
| 2015 | 1.47 |
| 2014 | 1.13 |
Journal of Labelled Compounds and Radiopharmaceuticals has an h-index of 56. It means 56 articles of this journal have more than 56 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Journal of Labelled Compounds and Radiopharmaceuticals is 03624803, 10991344. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Journal of Labelled Compounds and Radiopharmaceuticals is 17722. According to SCImago Journal Rank (SJR), this journal is ranked 0.271. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.271 |
| 2023 | 0.326 |
| 2022 | 0.440 |
| 2021 | 0.468 |
| 2020 | 0.432 |
| 2019 | 0.468 |
| 2018 | 0.359 |
| 2017 | 0.477 |
| 2016 | 0.603 |
| 2015 | 0.459 |
| 2014 | 0.372 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 17722 |
| 2023 | 14946 |
| 2022 | 11568 |
| 2021 | 10629 |
| 2020 | 11390 |
| 2019 | 10399 |
| 2018 | 12208 |
| 2017 | 9580 |
| 2016 | 7818 |
| 2015 | 9871 |
| 2014 | 11211 |
Journal of Labelled Compounds and Radiopharmaceuticals is published by John Wiley and Sons Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 1976-2024. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Journal of Labelled Compounds and Radiopharmaceuticals is J. Label. Compd. Radiopharm.. This abbreviation ('J. Label. Compd. Radiopharm.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Analytical Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Biochemistry (Q4); Drug Discovery (Q4); Organic Chemistry (Q4); Spectroscopy (Q4), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Journal of Labelled Compounds and Radiopharmaceuticals latest impact IF is 0.96. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 1.75 (2016) and 0.86 (2023), respectively, in the last 11 years. Moreover, its average IS is 1.38 in the previous 11 years.
The Journal of Labelled Compounds and Radiopharmaceuticals has an SJR (SCImago Journal Rank) of 0.271, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 0.603 in 2016 and the lowest being 0.271 in 2024. Furthermore, the average SJR of the Journal of Labelled Compounds and Radiopharmaceuticals over the previous 11-year period stands at 1.38.
The latest h-index of the Journal of Labelled Compounds and Radiopharmaceuticals is 56.
The Journal of Labelled Compounds and Radiopharmaceuticals is published by the John Wiley and Sons Ltd, with its country of publication being the United Kingdom.
The Journal of Labelled Compounds and Radiopharmaceuticals is currently ranked 17722 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 7818 in 2016 and its lowest position of 17722 in 2024.
The standard ISO4 abbreviation for the Journal of Labelled Compounds and Radiopharmaceuticals is J. Label. Compd. Radiopharm..
Journal of Labelled Compounds and Radiopharmaceuticals is classified as a journal that the John Wiley and Sons Ltd publishes.
The Journal of Labelled Compounds and Radiopharmaceuticals encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Journal of Labelled Compounds and Radiopharmaceuticals is assigned the following International Standard Serial Numbers (ISSN): 03624803, 10991344.
The best quartile for the Journal of Labelled Compounds and Radiopharmaceuticals is Q3 (2024).
The Journal of Labelled Compounds and Radiopharmaceuticals coverage history can be summarized as follows: 1976-2024.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Syntax | journal | 2676 | Wiley-Blackwell Publishing Ltd | 35 | 1.10 |
| Transnational Corporations | journal | 13970 | UNCTAD United Nations Conference on Trade and Development | 30 | 1.63 |
| Studies in Continuing Education | journal | 4850 | Routledge | 44 | 3.35 |
| Population Review | journal | 19550 | Sociological Demography Press | 15 | 0.59 |
| Exploration Geophysics | journal | 18330 | Taylor and Francis Ltd. | 52 | 0.90 |
| Rinsan Shikenj Oha/Journal of the Hokkaido Forest Products Research Institute | journal | 29148 | Hoikkaido Forest Products Research Institute | 4 | 0.00 |
| Museum Management and Curatorship | journal | 10490 | Routledge | 43 | 2.06 |
| Journal of Sociology | journal | 6357 | SAGE Publications Ltd | 66 | 2.82 |
| Consulting engineer Barrington | journal | 24079 | Cahners Pub. Co. | 0 | 0.00 |
| HOMO- Journal of Comparative Human Biology | journal | 17447 | Elsevier B.V. | 40 | 1.17 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.96 |
| 2023 | 0.86 |
| 2022 | 1.66 |
| 2021 | 1.72 |
| 2020 | 1.66 |
| 2019 | 1.52 |
| 2018 | 1.15 |
| 2017 | 1.27 |
| 2016 | 1.75 |
| 2015 | 1.47 |
| 2014 | 1.13 |
